Showing results (1-10 of 35) with videos related to
Sort By:
Pageof 4
Journal of Immunology (Baltimore, Md. : 1950)|February 23, 2008
Cutting edge: selective expression of inhibitory or activating killer cell Ig-like receptors in circulating CD4+ T lymphocytesNatacha Remtoula, Armand Bensussan, Anne Marie-CardineFrontiers in Immunology|September 16, 2017
Therapeutic Antibodies to KIR3DL2 and Other Target Antigens on Cutaneous T-Cell LymphomasChristian Schmitt, Anne Marie-Cardine, Armand BensussanJournal of Immunology (Baltimore, Md. : 1950)|December 26, 2008
Identification and characterization of a transmembrane isoform of CD160 (CD160-TM), a unique activating receptor selectively expressed upon human NK cell activationJérôme Giustiniani, Armand Bensussan, Anne Marie-CardineJournal of Immunology (Baltimore, Md. : 1950)|January 24, 2007
A soluble form of the MHC class I-specific CD160 receptor is released from human activated NK lymphocytes and inhibits cell-mediated cytotoxicityJérôme Giustiniani, Anne Marie-Cardine, Armand BensussanInternational Immunology|April 30, 2002
BY55/CD160 acts as a co-receptor in TCR signal transduction of a human circulating cytotoxic effector T lymphocyte subset lacking CD28 expressionMaria Nikolova, Anne Marie-Cardine, Laurence Boumsell, et al.The Journal of Investigative Dermatology|July 10, 2014
KIR3DL2/CpG ODN interaction mediates Sézary syndrome malignant T cell apoptosisBouchra Ghazi, Nicolas Thonnart, Martine Bagot, et al.Cellular Immunology|October 4, 2005
SC3 monoclonal antibody defines a novel specific human B-cell surface antigen differentially expressed on B-cell leukaemias and lymphomas and involved in the proliferation of normal and malignant B lymphocytesMaria Nikolova, Margarita Guenova, Hristo Taskov, et al.Critical Reviews in Immunology|August 9, 2003
Structure and function of the immune semaphorin CD100/SEMA4DAbdellah Elhabazi, Anne Marie-Cardine, Isabelle Chabbert-de Ponnat, et al.Oncoimmunology|September 26, 2015
A novel targeted immunotherapy for CTCL is on its way: Anti-KIR3DL2 mAb IPH4102 is potent and safe in non-clinical studiesHélène Sicard, Cécile Bonnafous, Ariane Morel, et al.The Journal of Investigative Dermatology|December 31, 2010
Expression and function of the natural cytotoxicity receptor NKp46 on circulating malignant CD4+ T lymphocytes of Sézary syndrome patientsArmand Bensussan, Natacha Remtoula, Simona Sivori, et al.Pageof 4